Pharming Historical Financial Ratios

PHAR Stock

USD 7.65 0.12 1.59%

Pharming Group is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 0.29, Invested Capital of 0.0, Average Payables of 10.8 M or Stock Based Compensation To Revenue of 0.0358 will help investors to properly organize and evaluate Pharming Group NV financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Pharming Financial Ratios Analysis

Pharming Group NVFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pharming Group investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pharming financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pharming Group history.

Pharming Group Financial Ratios Chart

At this time, Pharming Group's Average Payables is relatively stable compared to the past year. As of 11/26/2024, Payables Turnover is likely to grow to 2.96, while PTB Ratio is likely to drop 3.07.

Price To Sales Ratio Days Sales Outstanding Average Payables Capex To Depreciation Ev To Sales Ev To Operating Cash Flow

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Pharming Group NV stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pharming Group sales, a figure that is much harder to manipulate than other Pharming Group NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Most ratios from Pharming Group's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pharming Group NV current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

At this time, Pharming Group's Average Payables is relatively stable compared to the past year. As of 11/26/2024, Payables Turnover is likely to grow to 2.96, while PTB Ratio is likely to drop 3.07.

	2021	2022	2023	2024 (projected)
Payables Turnover	3.93	2.89	1.74	2.96
Days Of Inventory On Hand	493.38	879.68	821.73	780.64

Payables Turnover Days Of Inventory On Hand

Pharming Group fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.14	0.94	0.99	0.07	-0.96	-0.38	-0.15	0.14	1.0	-0.97	-0.14	0.28	-0.97	-0.27	0.26	-0.33	0.99	0.99	-0.24	-1.0	-0.19	-0.25	-0.15	-0.32	-0.08
Ptb Ratio	0.14		0.1	0.17	0.6	0.08	0.34	0.03	1.0	0.14	0.07	-0.66	0.07	-0.03	-0.08	-0.26	0.31	0.04	0.16	0.13	-0.12	0.29	0.15	0.1	0.2	-0.9
Days Sales Outstanding	0.94	0.1		0.92	0.07	-0.91	-0.43	-0.1	0.1	0.94	-0.91	-0.14	0.14	-0.9	-0.11	0.18	-0.25	0.93	0.91	-0.28	-0.94	-0.32	-0.29	-0.12	-0.34	-0.07
Book Value Per Share	0.99	0.17	0.92		0.17	-0.93	-0.29	-0.21	0.17	0.99	-0.94	-0.19	0.26	-0.94	-0.28	0.26	-0.24	0.97	1.0	-0.24	-0.99	-0.13	-0.23	-0.17	-0.25	-0.12
Free Cash Flow Yield	0.07	0.6	0.07	0.17		0.15	0.6	-0.15	0.6	0.08	0.14	-0.38	-0.2	0.14	-0.08	-0.1	0.76	0.01	0.14	0.11	-0.05	0.46	0.17	-0.19	0.51	-0.55
Operating Cash Flow Per Share	-0.96	0.08	-0.91	-0.93	0.15		0.51	0.17	0.08	-0.96	1.0	-0.04	-0.25	0.99	0.22	-0.29	0.48	-0.98	-0.94	0.31	0.97	0.33	0.32	0.14	0.41	-0.15
Average Payables	-0.38	0.34	-0.43	-0.29	0.6	0.51		-0.31	0.34	-0.38	0.5	-0.07	0.01	0.47	-0.35	-0.09	0.61	-0.42	-0.29	0.06	0.41	0.47	0.12	-0.2	0.51	-0.27
Capex To Depreciation	-0.15	0.03	-0.1	-0.21	-0.15	0.17	-0.31		0.03	-0.15	0.15	-0.01	0.27	0.13	-0.05	0.09	-0.12	-0.09	-0.23	0.27	0.15	0.29	0.27	0.06	-0.14	0.07
Pb Ratio	0.14	1.0	0.1	0.17	0.6	0.08	0.34	0.03		0.14	0.07	-0.66	0.07	-0.03	-0.08	-0.26	0.31	0.04	0.16	0.13	-0.12	0.29	0.15	0.1	0.2	-0.9
Ev To Sales	1.0	0.14	0.94	0.99	0.08	-0.96	-0.38	-0.15	0.14		-0.97	-0.14	0.28	-0.97	-0.27	0.26	-0.33	0.99	0.99	-0.24	-1.0	-0.19	-0.25	-0.15	-0.32	-0.08
Free Cash Flow Per Share	-0.97	0.07	-0.91	-0.94	0.14	1.0	0.5	0.15	0.07	-0.97		-0.04	-0.26	0.99	0.24	-0.3	0.47	-0.98	-0.94	0.29	0.97	0.31	0.31	0.15	0.4	-0.14
Roic	-0.14	-0.66	-0.14	-0.19	-0.38	-0.04	-0.07	-0.01	-0.66	-0.14	-0.04		0.16	0.0	-0.28	0.3	-0.14	-0.02	-0.17	0.14	0.11	-0.12	0.1	-0.3	-0.11	0.85
Inventory Turnover	0.28	0.07	0.14	0.26	-0.2	-0.25	0.01	0.27	0.07	0.28	-0.26	0.16		-0.33	-0.86	0.49	-0.21	0.3	0.28	0.25	-0.27	0.28	0.25	-0.42	-0.29	0.1
Net Income Per Share	-0.97	-0.03	-0.9	-0.94	0.14	0.99	0.47	0.13	-0.03	-0.97	0.99	0.0	-0.33		0.3	-0.28	0.47	-0.98	-0.95	0.25	0.98	0.28	0.26	0.14	0.39	-0.07
Days Of Inventory On Hand	-0.27	-0.08	-0.11	-0.28	-0.08	0.22	-0.35	-0.05	-0.08	-0.27	0.24	-0.28	-0.86	0.3		-0.58	-0.06	-0.3	-0.31	-0.28	0.26	-0.45	-0.32	0.63	-0.03	-0.19
Payables Turnover	0.26	-0.26	0.18	0.26	-0.1	-0.29	-0.09	0.09	-0.26	0.26	-0.3	0.3	0.49	-0.28	-0.58		-0.09	0.32	0.25	0.18	-0.29	0.25	0.21	-0.71	-0.01	0.39
Average Inventory	-0.33	0.31	-0.25	-0.24	0.76	0.48	0.61	-0.12	0.31	-0.33	0.47	-0.14	-0.21	0.47	-0.06	-0.09		-0.35	-0.26	0.36	0.35	0.48	0.41	-0.38	0.75	-0.26
Capex To Revenue	0.99	0.04	0.93	0.97	0.01	-0.98	-0.42	-0.09	0.04	0.99	-0.98	-0.02	0.3	-0.98	-0.3	0.32	-0.35		0.97	-0.21	-0.99	-0.18	-0.21	-0.19	-0.32	0.05
Cash Per Share	0.99	0.16	0.91	1.0	0.14	-0.94	-0.29	-0.23	0.16	0.99	-0.94	-0.17	0.28	-0.95	-0.31	0.25	-0.26	0.97		-0.24	-0.99	-0.14	-0.23	-0.17	-0.26	-0.1
Pocfratio	-0.24	0.13	-0.28	-0.24	0.11	0.31	0.06	0.27	0.13	-0.24	0.29	0.14	0.25	0.25	-0.28	0.18	0.36	-0.21	-0.24		0.25	0.63	0.99	-0.12	0.23	-0.01
Interest Coverage	-1.0	-0.12	-0.94	-0.99	-0.05	0.97	0.41	0.15	-0.12	-1.0	0.97	0.11	-0.27	0.98	0.26	-0.29	0.35	-0.99	-0.99	0.25		0.21	0.25	0.16	0.31	0.05
Capex To Operating Cash Flow	-0.19	0.29	-0.32	-0.13	0.46	0.33	0.47	0.29	0.29	-0.19	0.31	-0.12	0.28	0.28	-0.45	0.25	0.48	-0.18	-0.14	0.63	0.21		0.71	-0.2	0.39	-0.19
Pfcf Ratio	-0.25	0.15	-0.29	-0.23	0.17	0.32	0.12	0.27	0.15	-0.25	0.31	0.1	0.25	0.26	-0.32	0.21	0.41	-0.21	-0.23	0.99	0.25	0.71		-0.15	0.27	-0.03
Days Payables Outstanding	-0.15	0.1	-0.12	-0.17	-0.19	0.14	-0.2	0.06	0.1	-0.15	0.15	-0.3	-0.42	0.14	0.63	-0.71	-0.38	-0.19	-0.17	-0.12	0.16	-0.2	-0.15		-0.3	-0.34
Income Quality	-0.32	0.2	-0.34	-0.25	0.51	0.41	0.51	-0.14	0.2	-0.32	0.4	-0.11	-0.29	0.39	-0.03	-0.01	0.75	-0.32	-0.26	0.23	0.31	0.39	0.27	-0.3		-0.12
Roe	-0.08	-0.9	-0.07	-0.12	-0.55	-0.15	-0.27	0.07	-0.9	-0.08	-0.14	0.85	0.1	-0.07	-0.19	0.39	-0.26	0.05	-0.1	-0.01	0.05	-0.19	-0.03	-0.34	-0.12

Click cells to compare fundamentals

Pharming Group Account Relationship Matchups

Pharming Group fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ptb Ratio	8.37	4.41	2.58	3.68	3.42	3.07
Days Sales Outstanding	50.66	41.49	30.53	34.75	57.4	54.53
Book Value Per Share	0.0451	0.11	0.19	0.29	0.3	0.32
Free Cash Flow Yield	0.05	0.0921	0.0405	0.0278	(0.0277)	(0.0291)
Operating Cash Flow Per Share	0.12	0.14	0.0563	0.0353	(0.0263)	(0.0277)
Capex To Depreciation	4.39	1.84	0.85	0.15	0.13	0.12
Pb Ratio	8.37	4.41	2.58	3.68	3.42	3.07
Ev To Sales	5.1	3.35	2.46	3.46	3.23	3.07
Free Cash Flow Per Share	0.0784	0.12	0.0314	0.0323	(0.0286)	(0.03)
Roic	0.32	0.23	0.0609	0.0505	(0.0132)	(0.0125)
Inventory Turnover	1.48	1.2	0.74	0.41	0.44	0.42
Net Income Per Share	0.0647	0.0593	0.0249	0.0211	(0.0148)	(0.0156)
Days Of Inventory On Hand	247.27	305.26	493.38	879.68	821.73	780.64
Payables Turnover	4.47	1.88	3.93	2.89	1.74	2.96
Sales General And Administrative To Revenue	0.0904	0.11	0.0631	0.19	0.22	0.31
Research And Ddevelopement To Revenue	0.17	0.18	0.35	0.26	0.25	0.24
Capex To Revenue	0.13	0.0721	0.0841	0.009615	0.005306	0.005041
Pocfratio	13.17	8.9	13.77	32.86	(39.11)	(37.16)
Interest Coverage	5.11	12.83	4.71	3.4	(0.82)	(0.86)
Capex To Operating Cash Flow	0.34	0.18	0.44	0.0863	(0.0752)	(0.0715)
Pfcf Ratio	19.99	10.86	24.67	35.96	(36.06)	(34.26)
Days Payables Outstanding	81.65	194.05	92.91	126.27	209.98	276.64
Income Quality	1.09	1.92	1.64	1.53	1.81	0.91
Roe	0.35	0.21	0.083	0.0668	(0.0493)	(0.0517)
Ev To Operating Cash Flow	12.95	8.42	12.94	31.08	(45.8)	(43.51)
Pe Ratio	24.21	21.44	31.11	55.02	(69.36)	(65.89)
Return On Tangible Assets	0.23	0.12	0.0511	0.039	(0.0275)	(0.0289)
Ev To Free Cash Flow	19.66	10.28	23.18	34.02	(42.22)	(40.11)
Earnings Yield	0.0413	0.0466	0.0321	0.0182	(0.0144)	(0.0151)
Intangibles To Total Assets	0.31	0.22	0.21	0.18	0.17	0.16
Net Debt To E B I T D A	(0.25)	(0.8)	(0.65)	(1.21)	23.22	24.38
Current Ratio	1.05	3.43	5.33	4.65	3.67	2.22
Tangible Book Value Per Share	0.0606	0.14	0.17	0.2	0.19	0.35
Graham Number	0.52	0.62	0.41	0.39	0.32	0.3

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Pharming Historical Financial Ratios

About Pharming Financial Ratios Analysis

Pharming Group Financial Ratios Chart

Price To Sales Ratio

Average Payables

Capex To Depreciation

Ev To Sales

Ev To Operating Cash Flow

Pharming Group fundamentals Correlations

Pharming Group Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pharming Group fundamentals Accounts

Additional Tools for Pharming Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Cash Per Share	+ 1.0	Book Value Per Share
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Book Value Per Share	+ 0.99	Price To Sales Ratio
Capex To Revenue	+ 0.99	Price To Sales Ratio

Interest Coverage	- 1.0	Ev To Sales
Interest Coverage	- 1.0	Price To Sales Ratio
Interest Coverage	- 0.99	Cash Per Share
Interest Coverage	- 0.99	Capex To Revenue
Interest Coverage	- 0.99	Book Value Per Share
Capex To Revenue	- 0.98	Net Income Per Share